Saving changes...

Done

Error

Advanced Critical Care Therapeutics: Acute Coronary Syndromes

Advanced Critical Care Therapeutics: Acute Coronary Syndromes

Advanced Critical Care Therapeutics: Acute Coronary Syndromes

 Daniel E. Hilleman, PharmD, FCCP
Daniel E. Hilleman, PharmD, FCCP
on behalf of Creighton University School of Pharmacy and Health Professions

$20.00 $ 20.00 $ 20.00

$20.00 $ 20.00 $ 20.00

$ 20.00 $ 20.00 $ 20.00
$ 20.00 $ 20.00 $ 20.00
Normal Price: $20.00 $20.00

Review:

Launch date: 29 Mar 2017

Expiry Date:

Last updated: 30 May 2018

Reference: 176759

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This is a comprehensive presentation on Acute Coronary Syndrome (ACS) by Daniel Hilleman as a part of the Advanced Critical Care Therapeutic course.

The Advanced Critical Care Therapeutic course provides in-depth advanced instruction concerning the pharmacotherapeutic management of commonly encountered critical care diseases.  Emphasis is placed on the efficacy, safety, and comparative value of drug therapy in this highly specialized practice area.  Didactic knowledge of physiology, pharmacology, and drug therapy management is applied to disease states specific to this population.  Didactic instruction is combined with practice case studies and interactive discussions concerning critical care pharmacy-related issues.  Participants may download materials.   
The program is delivered to participants using a distance education platform.  Didactic lectures are electronically captured and packaged with written materials (references, case studies, self-evaluation quizzes) covering a total of 16 critical care topics.

Objectives

Objectives for STEMI - On completion of this course the learner will be able to:
- Define the clinical manifestations of acute coronary syndrome (ACS)
- Describe the pathophysiology of ACS
- Describe the criteria used to diagnose ACS
- Define when fibrinolytic therapy and percutaneous coronary intervention (PCI) is preferred for reperfusion in patients with STEMI
-Describe the pharmacologic characteristics of the available fibrinolytic agents
Identify absolute and relative contraindications to fibrinolytic therapy
- Describe the appropriate use of the following agents during the hospitalization of patients with STEMI.
-Anticoagulants
-Antiplatelet agents
-Oxygen
-Nitroglycerin
-Analgesia
-Beta-blockers
-RAAS modulators
-Tight glycemic control
-Magnesium
-Calcium channel blockers
-Describe appropriate secondary prevention measures in patients with STEMI.
Objectives for Non-STEMI/UAI - On completion of this course the learner will be able to:
-Describe the pathogenesis of non-ST elevation myocardial infarction (Non-STEMI) and unstable angina (UA)
-Describe the criteria used to diagnose Non-STEMI/UA
-Describe the early hospital management of patients presenting with Non-STEMI/UA, including: 
-Anti-ischemic therapy
-Anti-platelet therapy
-Anticoagulant
-Describe the appropriate use of antiplatelet and anticoagulant therapy in Non-STEMI/UA patients undergoing PCI
-Describe late hospital, discharge, and post-hospital care for patients with Non-STEMI/UA
-Be able to list the drugs that should be prescribed for secondary prevention in the NSTEMI patient and the UA patient
 Daniel E. Hilleman, PharmD, FCCP

Author Information Play Video Bio

Daniel E. Hilleman, PharmD, FCCP
on behalf of Creighton University School of Pharmacy and Health Professions

Professor of Pharmacy Practice
School of Pharmacy and
Health Professions  
Creighton University
hilleman@creighton.edu  
402-280-4288

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

undefined

Details

You must own the training to change the number

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error